Jaysynth Organchem Approves Q2 FY2027 Results

The Board inter alia approved the following items:

• Un-audited Standalone and Consolidated Financial Results for the quarter and half financial year ended 30th September, 2026, along with the Limited Review Report issued by M/s. Chhogmal & Co., Chartered Accountants, Statutory Auditor of the Company.

• Standalone and Consolidated Statement of Assets and Liabilities for the half financial year ended 30th September, 2026.

• Standalone and Consolidated Cash Flow Statement for the half financial year ended 30th September, 2026.

The meeting commenced at 12:00 Noon and concluded at 1:00 PM.